- Primary care clinicians hold wildly varying beliefs about the safety and efficacy of statins, but these biases do not seem to have much effect on their prescribing practices.
- A “high proportion” of patients still resist statins even when clinicians recommend the therapy.
Why this matters
- Despite guidelines-based increases in the number of patients who would be eligible for statins, adherence to these guidelines has been limited.
- 27.8% of providers thought statins were associated with developing diabetes, and 16.7% of providers brought this up with their patients.
- 97.2% thought statins caused myopathy, and 72.3% overall discussed that belief with patients.
- 77.7% used the 10-year atherosclerotic risk calculation always/very often.
- Most of them nailed the risk reduction ranges, although some cited very high or low estimates; 8 said statins have no effect on cardiovascular disease risk.
- Effect of provider beliefs on prescription uptake was marginal.
- 164 primary care clinicians in North Carolina surveyed in 2017; 43.9% completed the survey.
- Funding: American Heart Association; NIH.
- Regional study, single health system; pretty low response rate.